Filing Flows › Amneal Pharmaceuticals (AMRX) › Free cash flow
Amneal Pharmaceuticals (AMRX) free cash flow by quarter
Amneal Pharmaceuticals' free cash flow was $66.5M in Q3 2026 (third quarter 2026), -39% from Q4 2025. Over the last 4 quarters it ranged from $61.0M (Q2 2025) to $109M (Q4 2025).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $66.5M | -39% | -37% |
| Q4 2025 | $109M | +2% | — |
| Q3 2025 | $106M | +74% | — |
| Q2 2025 | $61.0M | — | — |
Q3 2026 at a glance
Amneal Pharmaceuticals, Q3 2026: revenue $863M (+10% year over year), operating margin 11.1%, net earnings $12.3M, operating cash flow $98.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Amneal Pharmaceuticals' free cash flow?
Amneal Pharmaceuticals' free cash flow was $66.5M in Q3 2026 (third quarter 2026), -39% from Q4 2025.
How has Amneal Pharmaceuticals' free cash flow changed?
Over the last 4 quarters it ranged from $61.0M (Q2 2025) to $109M (Q4 2025).
Q3 2026 results → · How Amneal Pharmaceuticals makes money →